Novo Nordisk shares surged 6.87% to $86.67 on Friday morning following the release of promising trial results for its new obesity treatment, amycretin. The company reported that the drug demonstrated significant weight-loss effects during a...
Tag : weight loss treatment
In a monumental shift, Novo Nordisk, the Danish pharmaceutical giant, has ascended to become the 12th most valuable company globally, surpassing Tesla, according to FactSet data. With a market capitalization of $604 billion, Novo Nordisk...